Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy Volunteers

NCT07181538 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Onconic Therapeutics Inc.